Welcome to the ValueWiki Alexion Pharmaceuticals, Inc. (ALXN) article! Register for free or click the "edit" link to contribute!

Alexion Pharmaceuticals, Inc. (ALXN)

(Redirected from ALXN)

This summary section needs content! Click Here to begin writing.

Have a question about Alexion Pharmaceuticals, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Funds w/ ALXN:	40
Rank:	312 / 351

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/18/08 12:11 pm	The Technical Indicator: U.S. markets teetering around five-year lows (at MarketWatch)
11/12/08 9:11 am	ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E (EDGAR Online)
11/11/08 10:11 am	Alexion President, COO Keiser to retire (AP)
11/11/08 9:11 am	David W. Keiser to Retire as President of Alexion (PR Newswire)
11/10/08 1:11 pm	Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting (PR Newswire)
11/05/08 9:11 am	ALEXION PHARMACEUTICALS INC Financials (EDGAR Online Financials)
11/04/08 7:11 pm	Biotechs Brew Up Strong Profits, Sales In Weak Economy (Investor's Business Daily)
11/04/08 10:11 am	Alexion to Present at Investor Conferences (PR Newswire)
10/30/08 3:10 pm	ALEXION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
10/29/08 2:10 pm	Late to the Party (at Motley Fool)